Characterization of the Role of Chromosome 1p Deletion in MYCN-Amplified Neuroblastoma |
University of California San Francisco / Miller Huang, PhD |
Young Investigator Grants |
2013 |
California |
Immunotherapy for Pediatric Atypical Teratoid/Rhabdoid Tumor |
Baylor College of Medicine / William Decker, PhD |
Reach Grants |
2013 |
Texas |
Engager T cells for the Adoptive Immunotherapy of Pediatric Malignancies |
Baylor College of Medicine / Stephen Gottschalk, MD |
Innovation Grants |
2013 |
Texas |
Multispecific T Cells for Adoptive Immunotherapy of Pediatric High Grade Glioma (HGG) |
Baylor College of Medicine / Nabil Ahmed, MD, MSc |
Innovation Grants |
2013 |
Texas |
Dissecting and Targeting the Wnt Signaling Pathway in Metastatic Osteosarcoma |
Baylor College of Medicine / Jason T. Yustein, MD, PhD |
Young Investigator Grants |
2013 |
Texas |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
The Phase I/II Trials Collaborative for Children, Adolescents, and Young Adults at UH Rainbow Babies & Children's Hospital and the Case Comprehensive Cancer Center |
Case Western Reserve University / Letterio, John MD & Matloub, Yousif MD |
Phase I/II Infrastructure Grants |
2013 |
Ohio |
An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas |
Cedars-Sinai Medical Center / Sandra Orsulic, PhD |
Innovation Grants |
2013 |
California |
Children's Hospital Colorado Experimental Therapeutics Program |
Children’s Hospital Colorado / Lia Gore, MD |
Phase I/II Infrastructure Grants |
2013 |
Colorado |
Nationwide Children's Hospital Phase I/II Infrastructure |
Research Institute at Nationwide Children's Hospital / Sarah O'Brien, MD and Timothy Cripe, MD, PhD |
Phase I/II Infrastructure Grants |
2013 |
Ohio |